TA323997
antibody from OriGene
Targeting: TRAF3IP2
ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA323997 - Provider product page
- Provider
- OriGene
- Product name
- Anti-TRAF3IP2 Rabbit Polyclonal Antibody
- Antibody type
- Polyclonal
- Description
- Anti-TRAF3IP2 Rabbit Polyclonal Antibody
- Host
- Rabbit
- Conjugate
- Unconjugated
- Epitope
- TRAF3IP2
- Isotype
- IgG
- Antibody clone number
- NULL
- Vial size
- 100 µl
- Concentration
- 1mg/ml
Submitted references IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling.
Qiu AW, Bian Z, Mao PA, Liu QH
Experimental & molecular medicine 2016 Dec 16;48(12):e280
Experimental & molecular medicine 2016 Dec 16;48(12):e280
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Predicted band size: 65 kDa . Positive control: Jurkat cell lysate. Recommended dilution: 1/200-1000. (Gel: 10%SDS-PAGE Lysate: 40 ug per lane Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 40 seconds)
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Predicted cell location: Cytoplasm . Positive control: Human colon cancer tissue . Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human colon cancer tissue using TRAF3IP2 antibody at dilution 1/30, on the right is treated with the fusion protein. (Original magnification:x200)
- Validation comment
- IHC